世界の感染症分子診断の市場規模は、2023年に520億ドルと評価され、2024年から2030年にかけて3.9%のCAGRで拡大すると予想されます。市場の急拡大を促す要因は、世界中で感染症の有病率が増加していることにあります。HIV/エイズ、肝炎、結核、呼吸器感染症などの疾患は、引き続き公衆衛生上の大きな課題を引き起こしており、高度な診断ソリューションが必要です。さらに、高齢者は感染症にかかりやすく、頻繁な診断検査を必要とするため、世界人口の高齢化が市場の成長に貢献しました。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Infectious Disease Molecular Diagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Infectious Disease Molecular Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Infectious Disease Molecular Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Infectious Disease Molecular Diagnostics Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Instruments
4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Infectious Disease Molecular Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Infectious Disease Molecular Diagnostics Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Polymerase Chain Reaction (PCR)
5.3.1. Polymerase Chain Reaction (PCR) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Multiplex PCR
5.3.2.1. Multiplex PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.2. Instruments
5.3.2.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.3. Reagents
5.3.2.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.4. Others
5.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Other PCR
5.3.3.1.1. Other PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. In Situ Hybridization
5.4.1. In Situ Hybridization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Instruments
5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Reagents
5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. Others
5.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.5.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Instruments
5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Reagents
5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.4. Others
5.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Chips and Microarrays
5.6.1. Chips and Microarrays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. Instruments
5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. Reagents
5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. Others
5.6.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Mass Spectrometry
5.7.1. Mass Spectrometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.2. Instruments
5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.3. Reagents
5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.4. Others
5.7.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Sequencing
5.8.1. Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8.2. Instruments
5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8.3. Reagents
5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8.4. Others
5.8.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Transcription Mediated Amplification
5.9.1. Transcription Mediated Amplification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.2. Instruments
5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.3. Reagents
5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.4. Others
5.9.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Others
5.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10.2. Instruments
5.10.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10.3. Reagents
5.10.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10.4. Others
5.10.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Infectious Disease Molecular Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Infectious Disease Molecular Diagnostics Market: Application Movement Analysis, USD Million, 2023 & 2030
6.3. Respiratory Diseases
6.3.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Tuberculosis
6.4.1. Tuberculosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Meningitis
6.5.1. Meningitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Gastrointestinal Tract Infections
6.6.1. Gastrointestinal Tract Infections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. HPV
6.7.1. HPV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Sexually Transmitted Infections
6.8.1. Sexually Transmitted Infections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Sepsis
6.9.1. Sepsis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Drug Resistance Diseases
6.10.1. Drug Resistance Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Others
6.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Infectious Disease Molecular Diagnostics Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Infectious Disease Molecular Diagnostics Market: End Use Movement Analysis, USD Million, 2023 & 2030
7.3. Hospitals
7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Clinics
7.4.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Diagnostics Laboratories
7.5.1. Diagnostics Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Research Institutes
7.6.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Infectious Disease Molecular Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Infectious Disease Molecular Diagnostics Market Share, By Region, 2023 & 2030, USD Million
8.2. North America
8.2.1. North America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. China Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Abbott
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Danaher Corporation
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. bioMérieux SA
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. F. Hoffmann-La Roche Ltd
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Bio-Rad Laboratories, Inc.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Agilent Technologies, Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Becton, Dickinson and Company
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Hologic, Inc. (Gen-Probe)
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Grifols S.A.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Qiagen
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. Siemens Healthineers AG
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/ Strategic Initiatives
9.4.12. Sysmex Corporation
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/ Strategic Initiatives
